Nearly two-thirds of high-risk patients prescribed PCSK9 inhibitors to lower their risk of familial hypercholesterolemia and ASCVD are rejected coverage for the drugs by their health insurers, a new study alleges.
Toward the end of June, around a dozen American diabetics took an 817-mile caravan ride from Minneapolis to London, Ontario, in an effort to obtain more affordable insulin, CBS News reports. It was the second caravan in two months to make the trip.
Multivitamins and the bulk of nutritional supplements do little to protect heart health, in some cases increasing a person’s risk for CV events, an analysis published in the Annals of Internal Medicine has found.
A lack of formal training in nutrition could significantly limit how physicians practice, according to an editorial published in JAMA Internal Medicine this month, in some cases leading them to recommend risky treatments to patients in lieu of dietary counseling that might be just as effective.
A bariatric surgeon at the Ohio State Wexner Medical Center is advocating for a new set of clinical guidelines that would extend eligibility for weight loss surgery to thousands more patients struggling with their weight.
Fear-based “fake news” about statin therapy is driving non-adherence to the drugs in the U.S., according to an editorial published in JAMA Cardiology June 26, fostering a culture of mistrust and misinformation that could easily deter heart patients from a treatment that might be beneficial to them.
Body fat distribution could be a key predictor of heart disease risk in postmenopausal women, according to a July 1 study that found “apple”-shaped women are more prone to CVD than their “pear”-shaped counterparts.